Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 5Phase 1 3Phase 4 2Phase 1/2 1

Status

Completed 4Terminated 1

Sponsor Class

INDUSTRY 4OTHER_GOV 1

Study Type

Interventional 5

Sponsor

Cancer Type

Other hematologic neoplasm 23Myeloid 21Sarcoma 5Gastrointestinal 4Lymphoid 2

Conditions

Gastrointestinal Stromal Tumors 4Sarcoma 1Neoplasms 1Neoplasm Metastasis 1

Interventions

Doxorubicin 40Radiotherapy 30Ifosfamide 28Vincristine 27Cyclophosphamide 24Imatinib Mesylate 20Etoposide 20Dactinomycin 14Radiation 13Filgrastim 11Temozolomide 9Sunitinib 9Trabectedin 8Methotrexate 8Specimen Handling 7Magnetic Resonance Spectroscopy 6Granulocyte Colony-Stimulating Factor 6Chemotherapy, Adjuvant 6pazopanib 5nilotinib 5Zoledronic Acid 5Neoadjuvant Therapy 5Irinotecan 5Cisplatin 5Carboplatin 5X-Rays 4Vinorelbine 4Topotecan 4Surgical Procedures, Operative 4Procarbazine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × nilotinib × Sarcoma × Clear all
NCT03784014 2026-04-29

MULTISARC

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Completed
603 enrolled
Sarcoma

Neoplasm Metastasis, Sarcoma

NCT01289028 2017-01-02

Efficacy of Nilotinib in Adult Patients With Gastrointestinal Stromal Tumors Resistant to Imatinib and Sunitinib.

Novartis

Phase 3 Completed
125 enrolled 11 charts
GastrointestinalSarcoma

Neoplasms, Gastrointestinal Stromal Tumors

NCT00785785 2016-06-16

ENESTg1

Novartis

Phase 3 Completed
644 enrolled 8 charts
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT00751036 2014-03-26

MACS0375

Novartis

Phase 3 Terminated
94 enrolled 10 charts
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT00471328 2012-06-12

ENEST

Novartis

Phase 3 Completed
248 enrolled 17 charts
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡